home / stock / trvi / trvi news


TRVI News and Press, Trevi Therapeutics Inc. From 08/10/23

Stock Information

Company Name: Trevi Therapeutics Inc.
Stock Symbol: TRVI
Market: NYSE
Website: trevitherapeutics.com

Menu

TRVI TRVI Quote TRVI Short TRVI News TRVI Articles TRVI Message Board
Get TRVI Alerts

News, Short Squeeze, Breakout and More Instantly...

TRVI - Trevi Therapeutics, Inc. (TRVI) Q2 2023 Earnings Call Transcript

2023-08-10 22:49:14 ET Trevi Therapeutics, Inc. (TRVI) Q2 2023 Earnings Conference Call August 10, 2023, 04:30 PM ET Company Participants Jennifer Good - President and Chief Executive Officer Lisa Delfini - Chief Financial Officer Conference Call Participants ...

TRVI - Trevi Therapeutics GAAP EPS of -$0.07 beats by $0.02

2023-08-10 17:48:49 ET Trevi Therapeutics press release ( NASDAQ: TRVI ): Q2 GAAP EPS of -$0.07 beats by $0.02 . The Company ended the second quarter of 2023 with $94.2 million in cash, cash equivalents and marketable securities. For further details see: Trev...

TRVI - Trevi Therapeutics Announces Second Quarter 2023 Financial Results and Provides Business Update

Trevi Therapeutics Announces Second Quarter 2023 Financial Results and Provides Business Update PR Newswire Plans to initiate three clinical studies in chronic cough indications for later this year remain on track Data from Phase 2 CANAL trial of chronic cough in patie...

TRVI - Trevi Therapeutics to Report Q2 2023 Financial Results and Provide a Corporate Update on August 10, 2023

Trevi Therapeutics to Report Q2 2023 Financial Results and Provide a Corporate Update on August 10, 2023 PR Newswire Conference call and webcast to be held at 4:30 p.m. EDT NEW HAVEN, Conn. , Aug. 3, 2023 /PRNewswire/ -- Trevi Therapeutics, Inc. (...

TRVI - Trevi Therapeutics to Participate in Upcoming August Events

Trevi Therapeutics to Participate in Upcoming August Events PR Newswire NEW HAVEN, Conn. , Aug. 1, 2023 /PRNewswire/ -- Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company developing the investigational therapy Haduvio™ ...

TRVI - Trevi Therapeutics to Participate in Upcoming July Investor Events

Trevi Therapeutics to Participate in Upcoming July Investor Events PR Newswire NEW HAVEN, Conn. , July 6, 2023 /PRNewswire/ -- Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company developing the investigational therapy Haduvio&#...

TRVI - OSTK, VKTX and TRVI are among pre market gainers

2023-06-28 08:20:24 ET OPKO Health ( OPK ) +20% a pproves Pfizer’s NGENLa, a Long-Acting Once-Weekly Treatment for Pediatric Growth Hormone Deficiency. Baosheng Media Group  ( BAOS ) +15% . Xponential Fitness ( XPOF ) +15% plunges amid shor...

TRVI - Tracking Ole Andreas Halvorsen's Viking Global Portfolio - Q1 2023 Update

2023-06-13 04:32:53 ET Summary Ole Andreas Halvorsen's 13F stock portfolio value increased to $21.31B in Q1 2023, with Visa, McKesson, UnitedHealth, Elevance Health, and General Electric as the largest holdings. New stakes were established in Lululemon Athletica, Sherwin-Williams,...

TRVI - Trevi Therapeutics to Participate in Upcoming June Conferences

Trevi Therapeutics to Participate in Upcoming June Conferences PR Newswire Dr. Toby Maher will be presenting data results from the Phase 2 CANAL trial in IPF chronic cough at American Cough Conference NEW HAVEN, Conn. , May 30, 2023 /PRNewswire/ -- ...

TRVI - QCOM, EGHT and PBYI are among after hour movers

2023-05-22 17:30:42 ET Gainers: Movella Holdings  ( MVLA ) +14% . Trevi Therapeutics ( TRVI ) +5% . QUALCOMM  ( QCOM ) +5% . Galera Therapeutics ( GRTX ) +4% . LivePerson ( LPSN ) +4% . Losers: Guardant Health (...

Previous 10 Next 10